Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Biologics-Ibd'
Biologics-Ibd published presentations and documents on DocSlides.
Understanding Biologics Biologics and Biosimilars
by calandra-battersby
Animation: What Are Biologics?. Production of Bio...
Inflammatory Bowel Disease
by kittie-lecroy
Anjali Morey, M.D., Ph.D.. Digestive Specialists,...
UK IBD twin and multiplex registry: Concordance and environmental risk factors of twins with IBD
by Soulmate
Dr. Hannah Gordon, Prof Timothy Orchard, . Dr. A...
Managing IBD Treatment of IBD
by celsa-spraggs
Management of IBD. Sprint or Marathon?. Challenge...
Biosimilars and biologics –
by gelbero
What does personalisation . mean . for you?. Ian N...
Biologics Effectiveness and
by ruby
Safety (BEST) Initiative: . Pilot Year. Azadeh Sho...
From Small Molecules to Biologics: The Biotech Revolution
by trish-goza
New Opportunities for Universities and Small Biot...
Developing a biologics service:
by cheryl-pisano
a Virtual Biologics Clinic. Dr Ben Parker PhD, MR...
©Immunotrex Biologics 2014 CONFIDENTIAL
by conchita-marotz
1. PEG Nanoparticles: . Production . and Drug Del...
The UK IBD Registry :
by leonard
Making information work for patients, their clinic...
Canine IBD Content:
by genevieve
Introduction. Canine IBD. Conclusions. References....
Managing Extraintestinal Manifestations in IBD
by fiona
Sara Horst MD MPH. Alan Moss MD . Extra-intestinal...
FactSheetNews from the IBD Help CenterARTHRITIS AND JOINT PAINArthriti
by joy
colon. It is important to see a rheumatologist whe...
Hepatobiliary Complications in IBD ; a Brief review
by FoxyLady
Farhad. . Zamani. MD. Professor of medicine ...
IBD Management in Primary Care:
by anderson
Keys to Successful Diagnosis, Treatment, and Ongoi...
1 st draft IBS/IBD Cross CCG pathway
by okelly
This based on the guidelines written . Dr. . Buâ€...
Jaimee Doucette T helper cells in IBD
by myesha-ticknor
Jaimee Doucette T helper cells in IBD Overview B...
Defining the IBD Opportunity
by aaron
Jim . Gelder. , CEO, HCB. Trey Wall, VP, IBD Stra...
Current and Emerging Treatments for IBD
by ellena-manuel
This program will include a discussion of . inves...
IBD sharing in the
by pamella-moone
1000 . Genomes Project Phase 3 data reveals relat...
IBD Standards – what next?
by tawny-fly
Richard Driscoll. Chairman. IBD Standards Group. ...
Iron deficiency anaemia in IBD
by trish-goza
Dr Manoko Seabi. Consultant gastroenterologist . ...
The Role of Twin Studies in IBD Research
by test
Dr Hannah Gordon. Clinical Research Fellow. Chels...
IBD AFRICA
by lindy-dunigan
AGM March 2012 . IBD PURPOSE STATEMENT. ". To be ...
Preventing and treating narcotic dependence in our IBD pati
by myesha-ticknor
Eva Szigethy MD, PhD . Associate Professor of Ps...
A look at IBD 2015
by tatyana-admore
80% . of stores were up. . for the day. S. ales ...
State of the Art in IBD Genetics
by alexa-scheidler
Judy H. Cho, M.D. . Ward-Coleman Professor of Med...
UK IBD twin and multiplex registry: Concordance and environ
by lois-ondreau
Dr. Hannah Gordon, Prof Timothy Orchard, . Dr. ...
Education pack for patients with Rheumatoid Arthritis treated with Biologics and Targeted synthetic
by anderson
at Dudley Group NHS FT . Dudley Rheumatology RA VB...
Large scale evidence generation for the utilisation and safety of biologic medicines
by quinn
. Associate Professor Nicole Pratt . Quality use o...
MONTH DAY, 20XX PRESENTATION TITLE CAN
by walsh
BE UP TO TWO LINES. PRESENTATION SUBTITLE CAN BE A...
PRESS RELEASE
by norah
1 Biocon Biologics’ New Monoclonal Antibodies ...
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
by iamamercy
Dr.G.Hima. . Bindu. ...
Bio similars A Presentation
by kittie-lecroy
By. ANSHUL . SHARMA. Graduate Research Scholar. D...
New Facility Preparation
by yoshiko-marsland
for Pre-Approval . Inspection . ...
Applying Biosimilars in Hematologic Cancers
by conchita-marotz
This program will include a discussion of off-lab...
How to Manage ISRs That Occur With Injectable Agents in Psoriasis
by faustina-dinatale
Introduction. MOA and Dosing of Approved Biologic...
Latin American Biologics/Biosimilars Conference
by giovanna-bartolotta
Presented by . the Alliance for Safe Bioloigic . ...
Immunology
by tatyana-admore
of Asthma . through Biologics . Private Practice ...
Common and Uncommon Extraintestinal
by rory286
Manifestations of Inflammatory Bowel Disease. Robe...
Load More...